Europe’s $89.7 Million Metagenomics Market, Forecast to 2027: Dominated by Illumina & Qiagen – ResearchAndMarkets.com
April 11, 2019DUBLIN–(BUSINESS WIRE)–The “Europe
Metagenomics Market to 2027 – Regional Analysis and Forecasts by
Product, Application and Country” report has been added to ResearchAndMarkets.com’s
offering.
The Europe Metagenomics market is expected to reach US$ 89.7 Mn in 2027
from US$ 48.6 Mn in 2018. The market is estimated to grow with a CAGR of
7.4% from 2018-2027.
The growth of the market is driven by the factors such as technological
advancements in the metagenomics, growing preference for Metagenomics
over traditional methods and wide range metagenomics applications, in
the Europe region. Whereas, highly priced metagenomics technology is
likely to have a negative impact on the growth of the market in the
coming years.
Metagenomics is the upcoming field of the biotechnology and the
extensive researches are being conducted in the labs across the world.
In addition, the next generation sequencing and other technologies in
the genomics are assisting in the conduction of the metagenomics studies.
Also, in recent years, next generation sequencing price have declined
substantially. For instance, first whole human genome sequencing cost
over US$3.7 billion in 2000 and took 13 years for the completion.
However, the costs for the same in recent years has reduced to US$1,000
and the process requires less number of days. In 2000, cost for
sequencing was US$ 3.7 billion, which dropped down to US$ 10 million in
2006 and declined to US$ 5,000 in 2012.
One of the few biotech unicorns in Europe, Oxford Nanopore Technologies
based in UK have introduced breakthrough technologies in DNA sequencing.
The company has developed handheld MinION sequencer to sequence the
human genome. The device was able to read sequences of DNA that are
hundreds times larger than usual, helping scientists better reconstruct
the whole genome sequence. MinION costs less than $1,000 and offers
high-speed sequencing even outside of the lab, with an accuracy of up to
99.96% when using ‘nanopolish’ software to correct any errors made
during sequencing.
Owing to factor that the cost of the metagenomics is been subsidize by
the venture capitalists and the innovative technology by the market
leaders that enables the access to the metagenomics studies are likely
to propel the growth of the market in the forecast period.
Germany is measured as the biggest hub for biotechnology in Europe and
across the world owing to presence of large biotechnology players,
high-tech research labs and massive funding for conduction of research
and development. Germany is a country where various biotechnological
companies reside than any other countries in Europe.
The country is also accounted in the international list of toppers for
the number of studies that are in pipeline. The cutting edge and
high-quality research present in the country creates lucrative
opportunity and presence of an established market for metagenomics.
Key Topics Covered
Part 1. Introduction
Part 2. Europe Metagenomics Market – Key Takeaways
Part 3. Europe Metagenomics Market – Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 Europe Metagenomics Market – by Product
3.2.2 Europe Metagenomics Market – by Application
3.2.3 Europe Metagenomics Market – by Country
3.3 Pest Analysis
Part 4. Europe Metagenomics Market – Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Technological Advancements In Metagenomics
4.1.2 Growing Preference For Metagenomics Over Traditional Methods
4.1.3 Wide Range of Metagenomics Applications
4.2 Key Market Restraints
4.2.1 Highly Priced Metagenomics Technology
4.3 Key Market Opportunities
4.3.1 Precision Metagenomic Analysis – Ushering In the Era of Precision
Medicine
4.4 Key Market Trends
4.4.1 Increasing Inclination Towards Molecular-Based Approaches
4.5 Impact Analysis
Part 5. Metagenomics Market – Europe Analysis
5.1 Europe Metagenomics Market Revenue Forecasts and Analysis
5.2 Market Positioning
5.3 Performance of Key Players
- Illumina Inc.
- Qiagen
5.4 Expert Opinions
Part 6. Europe Metagenomics Market Analysis – by Product
6.1 Overview
6.2 Europe Metagenomics Market, by Product, 2018 & 2027 (%)
6.3 Europe Metagenomics Market Revenue and Forecasts To 2027, by Product
(US$ Mn)
6.4 Instruments & Software Market
6.5 Consumables Market
Part 7. Europe Metagenomics Market Analysis – by Application
7.1 Overview
7.2 Europe Metagenomics Market, by Application, 2018 & 2027 (%)
7.3 Europe Metagenomics Market Revenue and Forecasts To 2027, by
Application (US$ Mn)
7.4 Clinical Diagnostic Market
7.5 Drug Discovery Metagenomics Market
7.6 Others Market
Part 8. Europe Metagenomics Market Revenue and Forecasts To 2027
8.1 Overview
8.2 Europe Metagenomics Market Revenue and Forecasts To 2027, by Country
(%)
8.3 UK Metagenomics Market Revenue and Forecasts To 2027 (US$ Mn)
8.4 Germany Metagenomics Market Revenue and Forecasts To 2027 (US$ Mn)
8.5 France Metagenomics Market Revenue and Forecasts To 2027 (US$ Mn)
Part 9. Metagenomics Market – Industry Landscape
9.1 Overview
9.2 Growth Strategies In the Metagenomics Market, 2015-2018
9.3 Organic Developments
9.4 Organic Growth Strategies In the Metagenomics Market, 2015-2018
9.5 Product Launch
9.6 Product Approval
9.7 Expansion & Others
9.8 Inorganic Developments
9.9 Inorganic Growth Strategies In the Metagenomics Market, 2015-2018
9.10 Acquisitions
9.11 Agreements
9.12 Partnership & Collaboration
Part 10. Metagenomics Market-Key Company Profiles
10.1 Merck KGaA
10.2 Thermo Fisher Scientific Inc.
10.3 Agilent Technologies Inc.
10.4 Qiagen
10.5 Bio-Rad Laboratories Inc.
10.6 Perkin Elmer Inc.
10.7 Illumina Inc.
10.8 F. Hoffmann-La Roche Ltd.
10.9 Oxford Nanopore Technologies Ltd.
10.10 Pacific Bioscience of California Inc.
For more information about this report visit https://www.researchandmarkets.com/r/8gjhm1
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Genomics